$ cat ./records/provided-750-million-seed-funding-to-create-the-gavi-vaccine-alli-2000.txt
Provided $750 million seed funding to create the GAVI vaccine alliance
[RECORD.TXT] · cat --full
The Gates Foundation provided $750 million in seed funding to establish GAVI, the Vaccine Alliance — a public-private partnership designed to increase access to vaccines in the world's lowest-income countries. The investment catalyzed contributions from governments, the WHO, UNICEF, and pharmaceutical companies. GAVI has since immunized over one billion children and is estimated to have saved more than 17 million lives.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
GAVI vaccine alliance launched at World Economic Forum Annual Meeting in Davos
Next →
Founded the Bill & Melinda Gates Foundation — the world's largest private charity
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.